NCT03144518View on ClinicalTrials.gov

Mood and Influenza Vaccine Response: A Feasibility Trial

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

November 1, 2017

Study Completion Date

May 31, 2018

Conditions
Vaccination; Infection
Interventions
OTHER

Positive Affect Intervention

See Previous Description

OTHER

Neutral Control Intervention

See Previous Description

BIOLOGICAL

Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)

Northern Hemisphere Influenza Vaccine 2017/18 (Delivered as part of Standard Care)

Trial Locations (1)

Unknown

University of Nottingham, Nottingham

All Listed Sponsors
collaborator

Northumbria University

OTHER

lead

University of Nottingham

OTHER

NCT03144518 - Mood and Influenza Vaccine Response: A Feasibility Trial | Biotech Hunter | Biotech Hunter